Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia - PubMed (original) (raw)
. 2014 Oct;20(10):O630-2.
doi: 10.1111/1469-0691.12564. Epub 2014 Feb 20.
J C Galbraith, L Valiquette, G Jacobsson, P Collignon, H C Schønheyder, M Søgaard, K J Kennedy, J D Knudsen, C Ostergaard, O Lyytikäinen, K B Laupland; International Bacteraemia Surveillance Collaborative
Collaborators, Affiliations
- PMID: 24461038
- DOI: 10.1111/1469-0691.12564
Free article
Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia
S Tom et al. Clin Microbiol Infect. 2014 Oct.
Free article
Abstract
Lethal outcomes can be expressed as a case fatality ratio (CFR) or as a mortality rate per 100 000 population per year (MR). Population surveillance for community-onset methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus bacteraemia was conducted in Canada, Australia, Sweden and Denmark to evaluate 30-day CFR and MR trends between 2000 and 2008. The CFR was 20.3% (MSSA 20.2%, MRSA 22.3%) and MR was 3.4 (MSSA 3.1, MRSA 0.3) per 100 000 per year. Although MSSA CFR was stable the MSSA MR increased; MRSA CFR decreased while its MR remained low during the study. Community-onset S. aureus bacteraemia, particularly MSSA, is associated with major disease burden. This study highlights complementary information provided by evaluating both CFR and MR.
Keywords: Bacteraemia; case fatality; mortality; staphylococcus.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
- Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB, Ross T, Gregson DB. Laupland KB, et al. J Infect Dis. 2008 Aug 1;198(3):336-43. doi: 10.1086/589717. J Infect Dis. 2008. PMID: 18522502 - The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.
Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schønheyder HC; International Bacteremia Surveillance Collaborative. Laupland KB, et al. Clin Microbiol Infect. 2013 May;19(5):465-71. doi: 10.1111/j.1469-0691.2012.03903.x. Epub 2012 May 23. Clin Microbiol Infect. 2013. PMID: 22616816 - Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC. Wang JL, et al. Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389. Clin Infect Dis. 2008. PMID: 18266610 - Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.
Pearson A, Chronias A, Murray M. Pearson A, et al. J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i11-7. doi: 10.1093/jac/dkp260. J Antimicrob Chemother. 2009. PMID: 19675013 Review. - MRSA bacteraemia.
Gould IM. Gould IM. Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S66-70. doi: 10.1016/j.ijantimicag.2007.06.023. Epub 2007 Sep 17. Int J Antimicrob Agents. 2007. PMID: 17875386 Review.
Cited by
- Biodistribution of the radionuclides (18)F-FDG, (11)C-methionine, (11)C-PK11195, and (68)Ga-citrate in domestic juvenile female pigs and morphological and molecular imaging of the tracers in hematogenously disseminated Staphylococcus aureus lesions.
Afzelius P, Nielsen OL, Alstrup AK, Bender D, Leifsson PS, Jensen SB, Schønheyder HC. Afzelius P, et al. Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):42-58. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27069765 Free PMC article. - Incidence of Monomicrobial Staphylococcus aureus Bacteremia: A Population-Based Study in Olmsted County, Minnesota-2006 to 2020.
Hindy JR, Quintero-Martinez JA, Lahr BD, Palraj R, Go JR, Fida M, Abu Saleh OM, Arshad V, Talha KM, DeSimone DC, Sohail MR, Baddour LM. Hindy JR, et al. Open Forum Infect Dis. 2022 Apr 13;9(7):ofac190. doi: 10.1093/ofid/ofac190. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35794939 Free PMC article. - Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality.
Bassetti M, Peghin M, Trecarichi EM, Carnelutti A, Righi E, Del Giacomo P, Ansaldi F, Trucchi C, Alicino C, Cauda R, Sartor A, Spanu T, Scarparo C, Tumbarello M. Bassetti M, et al. PLoS One. 2017 Feb 2;12(2):e0170236. doi: 10.1371/journal.pone.0170236. eCollection 2017. PLoS One. 2017. PMID: 28152067 Free PMC article. - A molecular epidemiological investigation of methicillin-susceptible Staphylococcus aureus causing bloodstream infections in Ireland, 2006-2017.
Deasy EC, Brennan GI, Tecklenborg SC, Umeh C, Coleman DC, Shore AC. Deasy EC, et al. Eur J Clin Microbiol Infect Dis. 2019 May;38(5):927-936. doi: 10.1007/s10096-019-03523-0. Epub 2019 Mar 23. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30904995 - Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series.
Lowe RA, Barber KE, Wagner JL, Bell-Harlan AM, Stover KR. Lowe RA, et al. J Pharmacol Pharmacother. 2017 Jul-Sep;8(3):140-144. doi: 10.4103/jpp.JPP_5_17. J Pharmacol Pharmacother. 2017. PMID: 29081626 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical